Schedule 13D ownership disclosure

CoLucid Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 19716T101

Event date: 2015-05-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-465471
Form type
SC 13D
Filer
CoLucid Pharmaceuticals, Inc.
CIK
CIK 1348649
Filed
Feb 16, 2016
Reporting period
May 11, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub

SC 13D | SEC Filings Hub